Colchicine may reduce myocardial damage after non-bypass heart surgery.

Published Date: 17 Feb 2023

China: Low-dose colchicine helps protect myocardium in surgery patients without CABG (coronary artery bypass graft).

Read Full News

Latest News

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

News All Time

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

‘Unchartered Territory’: CAR T Results in Ped Rheumatology

Among the challenges of conducting larger clinical trials is identifying appropriate patient populations.

Consider Kids’ Sports Gear as a Source of Contact Dermatitis

Modifications and alternative products can help manage sports-related allergens in children with allergic contact dermatitis.

Minority Families Describe Barriers to Pediatric Derm Care

Racially and ethnically minoritized communities perceive multiple barriers in accessing pediatric dermatology care, a study shows.

Recombinant Flu Shot Boosts Early Immune Response in Obesity

In patients with severe obesity, the recombinant influenza vaccine yields stronger short-term antibody responses than the egg-based standard-dose vaccine, with no safety concerns noted.

Glycoprotein Acetyls May Serve as a Biomarker for Psoriasis

Glycoprotein acetyls and phenylalanine are associated with psoriasis and joint involvement in the case of psoriatic arthritis, respectively, a cross-sectional study reveals.

Low Iodine Tied to Mortality in Women Post-Kidney Transplant

Lower dietary iodine intake is significantly associated with an increased risk for mortality in female, but not male, kidney transplant recipients, indicating a potential sex-specific vulnerability.

Real-World Data Show Avacopan Safety Signals in Vasculitis

Avacopan shows a favorable safety profile in ANCA-associated vasculitis in real-world settings, with hepatobiliary events as the leading safety concern and no adverse events of high clinical priority.

Paper Products Don’t Provoke Formaldehyde Reactions

Testing of various paper products available in the US yielded reassuring results.

Flu Vaccine Cuts Kids’ Hospitalization Risk by Up To 60%

The vaccine is 43% effective in reducing hospitalizations and medical visits due to influenza A (H3N2).

Safety of Tofacitinib vs Biologics in PsA: One Risk Differs

Tofacitinib shows safety comparable with biologics for PsA regarding serious infections, myocardial infarction or stroke, and malignancy but is tied to a higher risk for VTE than TNF inhibitors.

Early Oral Antibiotics: A Safe Shift in Bone Infections

Early switching from intravenous to oral treatment does not compromise treatment success in children with bone and joint infections and may reduce the risk for complications.

Recommended News For You

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.

Cancer during young adulthood carries long-term mental toll, study finds

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Recommended Articles For You

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Adopted cancer cells and the effects of their presence.

3.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

4.

Knowing about and avoiding bladder cancer.

5.

New drug combination shows good results in patients with HPV-negative head and neck cancer

1.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

2.

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification

3.

The Truth About Marijuana and Its Effect on Mental Health 

4.

Sorafenib: Understanding the science behind a powerful cancer drug 

5.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

3.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot